Your browser doesn't support javascript.
loading
Synergistic effect of nikkomycin Z with caspofungin and micafungin against Candida albicans and Candida parapsilosis biofilms.
Kovács, R; Nagy, F; Tóth, Z; Bozó, A; Balázs, B; Majoros, L.
Afiliação
  • Kovács R; Department of Medical Microbiology, Faculty of Medicine, University of Debrecen, Debrecen, Hungary.
  • Nagy F; Faculty of Pharmacy, University of Debrecen, Debrecen, Hungary.
  • Tóth Z; Department of Medical Microbiology, Faculty of Medicine, University of Debrecen, Debrecen, Hungary.
  • Bozó A; Department of Medical Microbiology, Faculty of Medicine, University of Debrecen, Debrecen, Hungary.
  • Balázs B; Department of Medical Microbiology, Faculty of Medicine, University of Debrecen, Debrecen, Hungary.
  • Majoros L; Department of Medical Microbiology, Faculty of Medicine, University of Debrecen, Debrecen, Hungary.
Lett Appl Microbiol ; 69(4): 271-278, 2019 Oct.
Article em En | MEDLINE | ID: mdl-31385615
ABSTRACT
Antifungal lock therapy has received significant interest in the last few years because the frequently usage of intravascular devices is associated with an increasing number of catheter-related bloodstream infections caused by Candida species. Antifungal combinations with synergistic interaction can be a good choice for antifungal lock therapy; therefore, interactions were examined between two echinocandins (caspofungin and micafungin) and the chitin synthesis inhibitor nikkomycin Z against Candida albicans and C. parapsilosis biofilms. Susceptibility was evaluated using the XTT-based checkerboard microdilution method, while the nature of interactions was assessed by calculating fractional inhibitory concentration indices and using the Bliss independence model. Mathematic-based evaluations were supplemented with fluorescent LIVE/DEAD viability assay. The results obtained by statistical interaction analyses correlated well with the viability assay. The tested echinocandins with nikkomycin Z caused an extended cell death and the structure of the biofilm was sparse compared to the control, especially for C. albicans. The findings support the simultaneous usage of nikkomycin Z and caspofungin or micafungin in alternative therapies such as the antifungal lock therapy. SIGNIFICANCE AND IMPACT OF THE STUDY Antifungal lock therapy can be a potential therapeutic approach to eradicate the intraluminal Candida biofilms; however, there is no approved lock strategy against fungal species so far. The results of this study provide valuable evidence that nikkomycin Z acts synergistically in combination with caspofungin or micafungin against biofilms. In addition, this synergy was more pronounced for micafungin combined with nikkomycin Z. Therefore, nikkomycin Z can be considered as a potential agent in antifungal lock therapy especially with micafungin against C. albicans or C. parapsilosis biofilms.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Candida albicans / Biofilmes / Candida parapsilosis / Caspofungina / Micafungina / Aminoglicosídeos / Antifúngicos Idioma: En Ano de publicação: 2019 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Candida albicans / Biofilmes / Candida parapsilosis / Caspofungina / Micafungina / Aminoglicosídeos / Antifúngicos Idioma: En Ano de publicação: 2019 Tipo de documento: Article